Exhibit 8.1


                          GUARDIAN BIOTECHNOLOGIES INC.


                             SUBSCRIPTION AGREEMENT


SUBSCRIPTION  AGREEMENT  made  as of this ______ day of _________, 200_, between
GUARDIAN  BIOTECHNOLOGIES  INC.,  a  Canada corporation (the "Company"), and the
undersigned  subscriber  (the  "Subscriber").

                                     RECITAL


The  Company  desires  to obtain financing by selling _________ shares of common
stock  (the  "Shares")  on  the  terms  described  in the current Prospectus for
Guardian Biotechnologies Inc., as supplemented or amended from time to time. The
Subscriber  desires to purchase that number of Shares set forth on the signature
page  hereof.

     NOW  THEREFORE,  for  and  in  consideration of the promises and the mutual
covenants  hereinafter set forth, the parties hereto do hereby agree as follows,
including  the  Recital:

1.     SUBSCRIPTION  FOR  SHARES  AND  REPRESENTATIONS  BY  THE  SUBSCRIBER

1.1     Subject  to the terms and conditions hereinafter set forth and described
in  the  current  Prospectus  for  Guardian Biotechnologies Inc., the Subscriber
subscribes  for  and  agrees  to  purchase the number of Shares for the purchase
price  set  forth upon the signature page hereof, and the Company agrees to sell
such  Shares  to  the  Subscriber  at  a  purchase  price  equal to such amount.
1.2     The  Subscriber  recognizes  that the purchase of Shares involves a high
degree  of risk and is suitable only for persons of adequate financial means who
have no need for liquidity in this investment in that (i) he/she may not be able
to  liquidate  his  or  her  investment  in  the  event  of  an  emergency; (ii)
transferability  is extremely limited; and (iii) he/she could sustain a complete
loss  of  his  or  her  entire  investment.
1.3     The Subscriber represents that (i) he/she is competent to understand and
does  understand  the  nature of the investment; and (ii) he/she is able to bear
the  economic  risk  of  this  investment.
1.4     Please  check  the  appropriate  space:
____     The  Subscriber represents that he/she is an "accredited investor". The
definition  of  an  "accredited  investor"  includes  the  following:
(a)  a  Canadian  financial institution, or an authorized foreign bank listed in
Schedule  III  of  the  Bank  Act  (Canada),
(b)  the  Business  Development  Bank  of Canada incorporated under the Business
Development  Bank  of  Canada  Act  (Canada),
(c)  an  association  under  the  Cooperative  Credit  Associations Act (Canada)
located  in  Canada,
(d)  a subsidiary of any person or company referred to in paragraphs (a) to (c),
if  the  person  or company owns all of the voting securities of the subsidiary,
except  the  voting  securities required by law to be owned by directors of that
subsidiary,
(e)  a  person  or company registered under the securities legislation, or under
the  securities  legislation of another jurisdiction of Canada, as an adviser or
dealer,  other  than a limited market dealer registered under the Securities Act
(Ontario),
(f)  an  individual  registered  or  formerly  registered  under  the securities
legislation,  or  under  the  securities  legislation of another jurisdiction of



Canada, as a representative of a person or company referred to in paragraph (e),
(g)  the  government of Canada or a province, or any crown corporation or agency
of  the  government  of  Canada  or  a  province,
(h)  a  municipality,  public  board  or  commission  in  Canada,
(i)  any  national,  federal,  state,  provincial,  territorial  or  municipal
government  of or in any foreign jurisdiction, or any agency of that government,
(j)  a pension fund that is regulated by either the Office of the Superintendent
of Financial Institutions (Canada) or a provincial pension commission or similar
regulatory  authority,
(k)  a  registered  charity  under  the  Income  Tax  Act  (Canada),
(l) an individual who, either alone or jointly with a spouse, beneficially owns,
directly  or  indirectly,  financial assets having an aggregate realizable value
that  before  taxes,  but  net  of  any related liabilities, exceeds $1,000,000,
(m) an individual whose net income before taxes exceeded $200,000 in each of the
two  most  recent years or whose net income before taxes combined with that of a
spouse exceeded $300,000 in each of the two most recent years and who, in either
case,  reasonably  expects  to exceed that net income level in the current year,
(n)  a corporation, limited partnership, limited liability partnership, trust or
estate, other than a mutual fund or non-redeemable investment fund, that had net
assets  of  at least $5,000,000 as shown on its most recently prepared financial
statements,
(o)  a  mutual  fund  or  non-redeemable  investment  fund  that,  in  the local
jurisdiction,  distributes  its securities only to persons or companies that are
accredited  investors,
(p)  a  mutual  fund  or  non-redeemable  investment  fund  that,  in  the local
jurisdiction,  distributes  its  securities  under  a  prospectus  for which the
regulator  has  issued  a  receipt,
(q)  an  entity  organized in a foreign jurisdiction that is analogous to any of
the entities referred to in paragraphs (a) through (e) and paragraph (j) in form
and  function,  or
(r)  a  person  or  company  in respect of which all of the owners of interests,
direct  or  indirect,  legal  or  beneficial,  are persons or companies that are
accredited  investors;
____     Family,  friends  and  business  associates  to  the  Company.
____     The  Subscriber  represents  that he/she is not a resident of Canada or
the  United  States.
1.5     The Subscriber acknowledges that he/she has significant prior investment
experience, including investment in non-listed and non-registered securities and
that  he/she  recognizes  the  highly  speculative  nature  of  this investment.
1.6     The  Subscriber  hereby represents that he/she has been furnished by the
Company  and by his or her representatives during the course of this transaction
with all information regarding the Company which he/she had requested or desired
to  know;  that all other documents which could be reasonably provided have been
made  available  for  his or her inspection and review; and that he/she has been
afforded  the  opportunity  to  ask  questions  of and receive answers from duly
authorized  officers  or  other  representatives  of  the Company concerning the
Company  and  the  terms  and  conditions  of this offering. The subscriber also
acknowledges  that  he/she has been directed to the Company's SEC EDGAR site and
has  had the filings therein available to him or her prior to entering into this
subscription  agreement.
1.7     The  Subscriber  agrees  that the Company may, if it desires, permit the
transfer  of  the  Securities by the Subscriber out of his or her name only when
his  or  her  request  for  transfer  is  accompanied  by  an opinion of counsel
reasonably  satisfactory  to  the  Company  that  the proposed sale, transfer or
disposition does not result in a violation of the Act or any applicable state or
province  "blue  sky"  laws  (collectively,  "Securities  Laws"). The Subscriber
agrees  to  hold the Company and its directors, officers and controlling persons
and their respective heirs, representatives, successors and assigns harmless and
to  indemnify  them against all liabilities, costs and expenses incurred by them
as  a result of any sale, transfer or other disposition of the Securities by the
undersigned  Subscriber  in  violation  of  any  Securities  Laws  or  any
misrepresentation  herein.
1.8     The  Subscriber  acknowledges  and agrees that the Company is relying on
the  Subscriber's  representations  contained  in  this Agreement in determining
whether  to  accept  this  subscription.  The Subscriber agrees that the Company
reserves the unrestricted right to reject or limit any subscription and to close
the  offer  at  any  time.
1.9     The  Subscriber represents and warrants that all representations made by



the Subscriber hereunder are true and correct in all material respects as of the
date  of  execution hereof, and Subscriber further agrees that until the closing
on  the Shares subscribed for he/she shall inform the Company immediately of any
changes  in  any  of  the  representations provided by the Subscriber hereunder.

2.     TERMS  OF  OFFERING

2.1     The  subscription  period  will  begin  as  of __________, 200_ and will
terminate  upon the date decided by the Company in its prospectus (the "Offering
Expiration  Date").
2.2     All  funds  paid  hereunder  in  settlement of the subscription shall be
immediately  available  to  the  Company.
2.3     The  Subscriber agrees to purchase the number of Shares from the Company
set  forth  upon  the  signature  page  hereof.
2.4     Closings  on investor subscriptions shall be held as soon as practicable
following  the  Company's  acceptance  hereof.

3.     MISCELLANEOUS

3.1     Any  notice  or  other  communication  given  hereunder  shall be deemed
sufficient  if  in  writing  and  sent  by  registered or certified mail, return
receipt  requested,  addressed  to  the  Company  at  IPW,  110 Gymnasium Place,
SASKATOON,  SASKATCHEWAN,  CANADA  S7N  0W9,  Attention:  President,  and to the
Subscriber  at his address indicated on the last page of this Agreement. Notices
shall  be  deemed  to  have been given on the date of mailing, except notices of
change  of  address,  which  shall  be  deemed to have been given when received.
3.2     This  Agreement  shall  not be changed, modified, or amended except by a
writing  signed  by  the  parties  to  be charged, and this Agreement may not be
discharged  except  by  performance in accordance with its terms or by a writing
signed  by  the  party to be charged. The respective representations, warranties
and  covenants of the parties set forth in this Agreement shall survive delivery
of  and  payment  for  the  Shares  contemplated  hereunder.
3.3     This  Agreement  shall  be  binding upon and inure to the benefit of the
parties  hereto and to their respective heirs, legal representatives, successors
and  assigns.  This  Agreement sets forth the entire agreement and understanding
between  the  parties  as to the subject matter hereof and merges and supersedes
all  prior  discussions,  agreements  and understandings of any and every nature
among  them.
3.4     This  Agreement  and its validity, construction and performance shall be
governed in all respects by the laws of the Canada, without giving effect to the
choice  of  law  rules  thereof.
3.5     This  Agreement  may be executed in counterparts. Upon the execution and
delivery  of  this  Agreement  by  the Subscriber, this Agreement shall become a
binding  obligation  of the Subscriber with respect to the purchase of Shares as
herein  provided.

     IN  WITNESS WHEREOF, the parties have executed this Agreement as of the day
and  year  first  written  above.

                              GUARDIAN  BIOTECHNOLOGIES  INC.
Date  of  Execution

                              By:  _________________________________

                              Its  _________________________________



TO  BE  COMPLETED  BY  INDIVIDUAL        TO  BE  COMPLETED  BY  CORPORATE,
SUBSCRIBERS                              PARTNERSHIP  OR  TRUST
                                         SUBSCRIBER




Name  of  Subscriber(s)                  Name  of  Subscriber
[Please  print]                          [Please  print]



                                         By:
Signature  of  Subscriber(s)             Authorized  Signatory


Address  of Subscriber                   Name and Title of Authorized Signature
                                         [Please  print]


Number  of  Shares Subscribed For at     Number of Shares Subscribed For at
$0.10  per  Share                        $0.10  per  Share


Total  Purchase  Price                   Total  Purchase  Price


Date  of  Execution                      Date  of  Execution




GUARDIAN  BIOTECHNOLOGIES  INC.  Subscription  form